Found 188 matching trials
Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years
PHASE1The purpose of this study is to generate safety, reactogenicity (assessment...
Location
GSK Investigational Site
Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)
PHASE2Vaccines are used to prevent infectious diseases worldwide. Unfortunately, ...
Location
Radboud University
Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA
PHASE1This is a randomized controlled parallel Group phase I study to investigate...
Location
University Hospital Bordeaux (Pellegrin Hospital)
A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers
PHASE2"Multimeric-001" (M-001) has been recently developed, containing conserved,...
Location
Hadassah medical center
Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
PHASE1The primary objective of the phase I trial is to evaluate the safety and to...
Location
Zigong Center for Disease Control and Prevention
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects
PHASE1Based on pre-clinical trial data and principle of GCP, the objective of pha...
Location
China-Japan Friendship Hospital
Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)
PHASE3The primary purpose of this study is to demonstrate the efficacy of an inve...
Location
Multiple Locations
Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection
PHASE2This study evaluates the efficacy, safety and immunogenicity of different f...
Location
George Washington University
Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine
PHASE1The purpose of this study is to evaluate the safety and immunogenicity of A...
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
PHASE1This research will study safety and the body's immune (defense system) resp...
Location
Emory Children's Center - Pediatric Infectious Diseases